These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

962 related articles for article (PubMed ID: 24332061)

  • 21. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
    Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
    Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
    World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
    Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Am J Clin Oncol; 2012 Apr; 35(2):136-40. PubMed ID: 21325937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
    Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative chemotherapy after neoadjuvant chemoradiation and surgery for rectal cancer: is it essential for patients with ypT0-2N0?
    Huh JW; Kim HR
    J Surg Oncol; 2009 Oct; 100(5):387-91. PubMed ID: 19582821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of oncologic outcomes of metastatic rectal cancer patients with or without neoadjuvant chemoradiotherapy.
    Kim SH; Kim JH; Jung SH
    Int J Colorectal Dis; 2015 Sep; 30(9):1193-9. PubMed ID: 26072129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.
    Fernández-Martos C; Pericay C; Aparicio J; Salud A; Safont M; Massuti B; Vera R; Escudero P; Maurel J; Marcuello E; Mengual JL; Saigi E; Estevan R; Mira M; Polo S; Hernandez A; Gallen M; Arias F; Serra J; Alonso V
    J Clin Oncol; 2010 Feb; 28(5):859-65. PubMed ID: 20065174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial.
    Schrag D; Weiser MR; Goodman KA; Gonen M; Hollywood E; Cercek A; Reidy-Lagunes DL; Gollub MJ; Shia J; Guillem JG; Temple LK; Paty PB; Saltz LB
    J Clin Oncol; 2014 Feb; 32(6):513-8. PubMed ID: 24419115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rectal cancer adjuvant chemotherapy: when is more useful?
    Pasetto LM; Basso U; Sinigaglia G; Pucciarelli S; Friso ML; Rugge M; Toppan P; Agostini M; Monfardini S
    Anticancer Res; 2008; 28(3B):1805-12. PubMed ID: 18630464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
    Tepper JE; O'Connell M; Niedzwiecki D; Hollis DR; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA; Mayer RJ
    J Clin Oncol; 2002 Apr; 20(7):1744-50. PubMed ID: 11919230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.
    Zhao L; Bai C; Shao Y; Guan M; Jia N; Xiao Y; Qiu H; Zhang F; Yang T; Zhong G; Chen S
    Cancer Lett; 2011 Nov; 310(2):134-9. PubMed ID: 21782322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.
    Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Janjan NA; Delclos ME; Krishnan S; Levy LB; Ellis LM; Crane CH
    Am J Clin Oncol; 2006 Jun; 29(3):219-24. PubMed ID: 16755173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of neoadjuvant treatment in cT3N0M0 rectal cancer.
    Pasetto LM; Friso ML; Pucciarelli S; Basso U; Rugge M; Sinigaglia G; Rossi E; Compostella A; Toppan P; Agostini M; Monfardini S
    Anticancer Res; 2008; 28(6B):4129-35. PubMed ID: 19192672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tailored selection of the interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer: analysis based on the pathologic stage or chemoradiation response.
    You KY; Huang R; Zhang LN; Ding PR; Xiao WW; Qiu B; Chang H; Zeng ZF; Pan ZZ; Gao YH
    J Cancer Res Clin Oncol; 2015 Apr; 141(4):719-28. PubMed ID: 25296560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local excision following pre-operative chemoradiotherapy-induced downstaging for selected cT3 distal rectal cancer.
    Yeo SG; Kim DY; Kim TH; Kim SY; Chang HJ; Park JW; Choi HS; Oh JH
    Jpn J Clin Oncol; 2010 Aug; 40(8):754-60. PubMed ID: 20457724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy.
    Kim MK; Cho KJ; Park SI; Kim YH; Kim JH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Song HJ; Ryu JS; Kim SB
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):115-21. PubMed ID: 19251379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study.
    Okuyama T; Sameshima S; Takeshita E; Yoshioka R; Yamagata Y; Ono Y; Tagaya N; Noie T; Oya M
    World J Surg Oncol; 2018 Jun; 16(1):105. PubMed ID: 29871650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis.
    Shin US; Yu CS; Kim JH; Kim TW; Lim SB; Yoon SN; Yoon YS; Kim CW; Kim JC
    Ann Surg Oncol; 2011 Aug; 18(8):2232-9. PubMed ID: 21347780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.